MiNK Therapeutics (INKT) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 14, 2026

Net selling: insiders sold $73K and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: -$73K net
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes
Federal contractsUSAspending.gov, 12 months: No awards

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

Unlock the full results

Questions about INKT filings

Are insiders buying or selling Mink Therapeutics Inc (INKT) stock?

Net selling: insiders sold $73K and bought $0 of INKT stock on the open market in the 90 days to Nov 14, 2026, according to SEC Form 4 filings. The largest was Buell, Jennifer (Chief Executive Officer), who sold $73K. The latest filing was on Oct 14, 2026.

Which members of Congress have traded INKT recently?

None. No member of Congress disclosed a INKT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this INKT smart-money data?

This summary uses filings available on Nov 14, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Smart money on INKT

Lean short1 source:
- Insiders

Top traders
Couldn't load this source
Insiders
- Barbara Ryan, sold $19.1K, open market, filed Jun 5
- Jennifer Buell, sold $73.3K, scheduled plan sale, filed Oct 14
Lean short · thin2 sales · $92.4K
1 of 2 on scheduled plans. Form 4 filings.
Congress
No recent politician filings found
Funds
No recent fund filings found
Influencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about INKT filings

Are insiders buying or selling Mink Therapeutics Inc (INKT) stock?

Which members of Congress have traded INKT recently?

None. No member of Congress disclosed a INKT trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this INKT smart-money data?

Insiders

What insiders are doing

2 trades · 6 mo

Sold$92K

Sells (2)

BJ
Buell Jennifer
Chief Executive Officer · Oct 14
$73K
sold
RB
Ryan Barbara
Dir · Jun 5
$19K
sold

Unlock everything for $29/month

Unlock for $29/month

Reported Nov 12, 2026

Earnings came in 14.5% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Nov 12, 2026

Period ending

Sep 30, 2026

Earnings per share

-$0.50+14.53% beat

-$0.58 expected

Revenue

$200.0K

SEC filing

EPS: Yahoo Finance

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Sep 30, 2026Reported Nov 12, 2026	-$0.50est. -$0.58	+14.53%beat	$200.0KSEC filing	No year-ago quarter
Jun 30, 2026Reported Aug 13, 2026	-$0.62est. -$0.60	-3.33%miss	$0.00Yahoo Finance	No year-ago quarter
Mar 31, 2026Reported May 15, 2026	-$0.57est. -$0.77	+25.97%beat	$0.00Yahoo Finance	No year-ago quarter
Dec 31, 2025Reported Mar 31, 2026	-$0.56est. -$0.68	+17.65%beat	$0.00Yahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 14, 2025	-$0.65est. -$0.85	+23.53%beat	Not on file	Not on file
Jun 30, 2025Reported Aug 14, 2025	-$1.06est. -$0.55	-92.73%miss	Not on file	Not on file
Mar 31, 2025Reported May 15, 2025	-$0.70est. -$0.61	-14.75%miss	Not on file	Not on file
Dec 31, 2024Reported Mar 18, 2025	-$0.62est. -$0.08	-$0.54miss	Not on file	Not on file

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $10.20
High: $10.38
Low: $9.53
Prev close: $10.22
52-wk high: $16.93
52-wk low: $8.48
Mkt cap: $52.2M
ROE: -1239.0%
Beta: 0.45
P/B: 11.3x
Profit margin: +0.0%
Op margin: +0.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $52M

Valuation

P/B11.33

Quality

Operating margin0.0%
ROE-1239.0%
ROA-123.8%

Growth

Beta0.45

Technicals

Price structure

This stock is under pressure.

Trend

Under pressure

0 / 100

RSI 14

36balanced

20D volatility

65%annualized

52-week range

$9.53

$8.48$16.93

20D support

$9.19recent floor

20D resistance

$11.68recent ceiling

Returns

5D -5.2%20D -4.1%60D -14.4%

Price vs moving averages

SMA20 -7.6%SMA50 -14.4%SMA200 -14.9%

Volume pace

0.61xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Sep 30, 2026Nov 12, 2026

-$0.50est. -$0.58

+14.53%

$200.0KSEC filing

No year-ago quarter

Jun 30, 2026Aug 13, 2026

-$0.62est. -$0.60

-3.33%

$0.00Yahoo Finance

No year-ago quarter

Mar 31, 2026May 15, 2026

-$0.57est. -$0.77

+25.97%

$0.00Yahoo Finance

No year-ago quarter

Dec 31, 2025Mar 31, 2026

-$0.56est. -$0.68

+17.65%

$0.00Yahoo Finance

No year-ago quarter

Sep 30, 2025Nov 14, 2025

-$0.65est. -$0.85

+23.53%

Not on file

Jun 30, 2025Aug 14, 2025

-$1.06est. -$0.55

-92.73%

Not on file

Mar 31, 2025May 15, 2025

-$0.70est. -$0.61

-14.75%

Not on file

Dec 31, 2024Mar 18, 2025

-$0.62est. -$0.08

-$0.54

Not on file

Mink Therapeutics Inc

Smart money at a glance

What do analysts expect?

Questions about INKT filings

Smart money on INKT

Questions about INKT filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 14.5% above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Mink Therapeutics Inc

Smart money at a glance

What do analysts expect?

Questions about INKT filings

Smart money on INKT

Questions about INKT filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 14.5% above what analysts expected.

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Mink Therapeutics Inc

Overview

Questions about INKT filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Mink Therapeutics Inc

Overview

Questions about INKT filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.